New cancer clinical trial: Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
Published on: July 18, 2017 at 12:00PM
Condition: Glioblastoma
Interventions: Drug: Poly-ICLC; Device: Tumor Treating Fields; Biological: Peptides
Sponsors: Adilia M Hormigo; NovoCure Ltd.
Not yet recruiting – verified July 2017
http://ift.tt/2tGV9GZ
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM